| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 106,262 | 79,155 | 76,719 | 125,180 | | Cost of Revenue | 66,783 | 53,869 | 66,128 | 80,571 | | | Gross Profit | 39,479 | 25,286 | 10,591 | 44,609 | | | Operating Expenses | | Research Development | 12,114 | 12,285 | 15,463 | 19,277 | | Selling General and Administrative | 24,385 | 25,667 | 28,464 | 30,518 | | Non Recurring | 168 | 208,565 | 5,620 | 6,069 | | Others | 871 | 1,011 | 1,653 | 1,949 | | | | Total Operating Expenses | 37,538 | 247,528 | 51,200 | 57,813 | | | | Operating Income or Loss | 1,941 | (222,242) | (40,609) | (13,204) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 316 | 266 | 1,057 | 1,256 | | Earnings Before Interest And Taxes | 2,257 | (221,976) | (39,552) | (11,948) | | Interest Expense | 53 | 53 | 48 | (31) | | Income Before Tax | 2,204 | (222,029) | (39,600) | (11,917) | | Income Tax Expense | 6,177 | (14,895) | (23,101) | (5,627) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,973) | (207,134) | (16,499) | (6,290) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,973) | (207,134) | (16,499) | (6,290) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($3,973) | ($207,134) | ($16,499) | ($6,290) |
|
0.83% Nasdaq 
0.19 (1.11%) 
Income Statement
